Company Dystrogen Gene Therapies
KRS
0000799476
NIP
5213873826
REGON
38412453000000
Management
Siemionow Krzysztof Borys, prezes zarządu
Beneficiaries of
1 beneficiary
More ›
| Rating | |||
| Main industry | Research and experimental development on biotechnology | ||
PKD codes:
72.11.Z - Research and experimental development on biotechnology
DYSTROGEN GENE THERAPIES was established on 2019-08-14 and is currently located at UL. WŁADYSŁAWA PYTLASIŃSKIEGO 10/12, PL-00-777, WARSZAWA. The main activity of the company is scientific research and development. As per the latest entry in the National Court Register, the current management board of the company comprises 1 individual(s). The most recent update in the National Court Register was recorded on 2023-12-18.